Department of General Surgery, The First Medical Center of Chinese PLA General Hospital, Beijing 100853, China; The Second School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.
Zhujiang Hospital, Southern Medical University, Guangzhou 510515, China.
Int Immunopharmacol. 2023 Jun;119:110194. doi: 10.1016/j.intimp.2023.110194. Epub 2023 Apr 18.
Most studies on melatonin have focused on tumor cells but have ignored the tumor microenvironment (TME), especially one of its important components, the cancer-associated fibroblasts (CAFs). Therefore, we attempted to explore the role of melatonin in TME.
We investigated the regulatory role of melatonin in the tumor-promoting effect of CAFs and its underlying mechanism by using cell and animal models.
CAFs promoted tumor progression, but melatonin weakened the tumor-promoting effect of CAFs. Compared with tumor cells, IL-8 was mainly expressed in CAFs. CAFs-overexpressing IL-8 induced the epithelial-mesenchymal transition (EMT) of tumor cells, and a positive crosstalk was observed between CAFs and tumor cells undergoing EMT, thereby further promoting the IL-8 expression. Melatonin suppressed this crosstalk by inhibiting the NF-κB pathway, thereby impeding the IL-8 expression from CAFs. Importantly, melatonin reversed CAFs-derived IL-8-mediated EMT by inhibiting the AKT pathway. Melatonin was found to directly and indirectly inhibit tumor progression.
Our research reveals the potential action mechanism of melatonin in regulating the CAF-tumor cell interaction and suggests the potential of melatonin as an adjuvant of tumor therapy.
大多数关于褪黑素的研究都集中在肿瘤细胞上,但忽略了肿瘤微环境(TME),特别是其重要组成部分之一——癌相关成纤维细胞(CAFs)。因此,我们试图探讨褪黑素在 TME 中的作用。
我们通过细胞和动物模型研究了褪黑素在 CAFs 促进肿瘤作用中的调节作用及其潜在机制。
CAFs 促进肿瘤进展,但褪黑素削弱了 CAFs 的促肿瘤作用。与肿瘤细胞相比,IL-8 主要在 CAFs 中表达。CAFs 过表达 IL-8 诱导肿瘤细胞发生上皮间质转化(EMT),并且观察到 EMT 过程中的 CAFs 和肿瘤细胞之间存在正相互作用,从而进一步促进了 IL-8 的表达。褪黑素通过抑制 NF-κB 通路抑制这种相互作用,从而抑制 CAFs 中的 IL-8 表达。重要的是,褪黑素通过抑制 AKT 通路逆转了 CAFs 衍生的 IL-8 介导的 EMT。褪黑素被发现可以直接和间接地抑制肿瘤进展。
我们的研究揭示了褪黑素调节 CAF-肿瘤细胞相互作用的潜在作用机制,并表明褪黑素作为肿瘤治疗辅助剂的潜力。